Publications

Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

Danielson, L. S., Park, D. S., Rotllan, N., Chamorro-Jorganes, A., Guijarro, M. V., Fernandez-Hernando, C., Fishman, G. I., Phoon, C. K., & Hernando, E. (2013). FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 27(4), 1460–1467.

PMID: 23271053

Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors That Express Pdgfrα but Not Kit

Pelczar, P., Zibat, A., van Dop, W. A., Heijmans, J., Bleckmann, A., Gruber, W., Nitzki, F., Uhmann, A., Guijarro, M. V., Hernando, E., Dittmann, K., Wienands, J., Dressel, R., Wojnowski, L., Binder, C., Taguchi, T., Beissbarth, T., Hogendoorn, P. C., Antonescu, C. R., Rubin, B. P., … Hahn, H. (2013). Gastroenterology, 144(1), 134–144.e6.

PMID: 23041331

Serum microRNAs as biomarkers for recurrence in melanoma

Friedman, E. B., Shang, S., de Miera, E. V., Fog, J. U., Teilum, M. W., Ma, M. W., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Hernando, E., Baker, A., Shao, Y., & Osman, I. (2012). Journal of translational medicine, 10, 155.

PMID: 22857597

Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site

Ma, M. W., Qian, M., Lackaye, D. J., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Golfinos, J. G., Parker, E. C., Darvishian, F., Hernando, E., Shao, Y., & Osman, I. (2012). Neuro-oncology, 14(7), 849–858.

PMID: 22561799

Histology-specific microRNA alterations in melanoma

Poliseno, L., Haimovic, A., Segura, M. F., Hanniford, D., Christos, P. J., Darvishian, F., Wang, J., Shapiro, R. L., Pavlick, A. C., Berman, R. S., Hernando, E., Zavadil, J., & Osman, I. (2012). The Journal of investigative dermatology, 132(7), 1860–1868.

PMID: 22551973

MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells

Alvarez-Díaz, S., Valle, N., Ferrer-Mayorga, G., Lombardía, L., Herrera, M., Domínguez, O., Segura, M. F., Bonilla, F., Hernando, E., & Muñoz, A. (2012). Human molecular genetics, 21(10), 2157–2165.

PMID: 22328083

MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.

Liu, Z., Liu, J., Segura, M. F., Shao, C., Lee, P., Gong, Y., Hernando, E., & Wei, J. J. (2012). The Journal of pathology, 228(2), 204–215.

PMID: 22322863

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma

Huynh, C., Poliseno, L., Segura, M. F., Medicherla, R., Haimovic, A., Menendez, S., Shang, S., Pavlick, A., Shao, Y., Darvishian, F., Boylan, J. F., Osman, I., & Hernando, E. (2011). PloS one, 6(9), e25264.

PMID: 21980408

MiR-30b/30d regulation of GalNAc transferases enhances invasion and synthesis of the immunosuppressive cytokine IL-10 during metastasis

Gaziel-Sovran, A., Segura, M. F., Di Micco, R., Collins, M. K., Hanniford, D., Vega-Saenz de Miera, E., Rakus, J. F., Dankert, J. F., Shang, S., Kerbel, R. S., Bhardwaj, N., Shao, Y., Darvishian, F., Zavadil, J., Erlebacher, A., Mahal, L. K., Osman, I., & Hernando, E. (2011). Cancer cell, 20(1), 104–118.

PMID: 21741600

Clinical variables and primary melanoma characteristics predictive of the development of brain metastases and survival in melanoma patients

Zakrzewski, J., Geraghty, L. N., Rose, A. E., Christos, P. J., Mazumdar, M., Polsky, D., Shapiro, R., Berman, R., Darvishian, F., Hernando, E., Pavlick, A., & Osman, I. (2011). Cancer, 117(8), 1711–1720.

PMID: 21061370

Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression

Rose, A. E., Poliseno, L., Wang, J., Clark, M., Pearlman, A., Wang, G., Vega Y Saenz de Miera, E. C., Medicherla, R., Christos, P. J., Shapiro, R., Pavlick, A., Darvishian, F., Zavadil, J., Polsky, D., Hernando, E., Ostrer, H., & Osman, I. (2011). Cancer research, 71(7), 2561–2571.

PMID: 21343389